Nortech Systems (NASDAQ:NSYS) Reports Q3 2025 Financials, Adjusted EBITDA Rises

Minneapolis, November 13, 2025 — Nortech Systems Incorporated (Nasdaq: NSYS) today released its financial results for the third quarter ending September 30, 2025, highlighting a net sales of $30.5 million compared to $31.4 million in Q3 2024, and an adjusted EBITDA of $1.3 million, a significant increase from $0.1 million in the same period last year.

The company reported a net loss of $(146) thousand, or $(0.05) per basic share, an improvement from the $(739) thousand, or $(0.27) per basic share loss in Q3 2024. As of September 30, 2025, Nortech’s 90-day backlog stood at $31.3 million, up from $29.6 million the previous year.

President and CEO Jay D. Miller credited the results to the company’s restructuring efforts and cost discipline. Miller noted a positive shift from first builds to recurring production, driven by increased manufacturing efficiencies, and expressed pride in the team’s execution and focus.

Nortech Systems also announced its Monterrey, Mexico facility achieved AS9100:D certification, demonstrating the company’s ability to deliver complex, high-reliability products for demanding aerospace and industrial applications. Miller believes this certification enhances the company’s service offerings and positions it to leverage its operational performance in the current nearshoring landscape.

The company will host a live conference call and webcast at 3:30 p.m. Central Time today to discuss the results, led by CEO Jay D. Miller and CFO Andrew D. C. LaFrence.

Summary of Third Quarter 2025 Financial Results (in thousands of dollars):

Net sales: $30,482 vs $31,407 in Q3 2024 (% Change (2.9)%)
Gross profit: $5,025 vs $3,835 in Q3 2024 (31.0 %)
Operating expenses: $4,080 vs $4,302 in Q3 2024 ((5.2)%)
Net (loss) income: $(146) vs $(739) in Q3 2024 (80.2%)
EBITDA: $1,253 vs $(33) in Q3 2024 (3,897%)
Adjusted EBITDA: $1,253 vs $143 in Q3 2024 (776.2%)

Summary of Year-to-Date 2025 Financial Results (in thousands of dollars):

Net sales: $88,052 vs $99,513 in YTD 2024 (% Change (11.5)%)
Gross profit: $12,940 vs $13,900 in YTD 2024 ((6.9)%)
Operating expenses: $12,866 vs $12,868 in YTD 2024 (0.0%)
Net (loss) income: $(1,149) vs $183 in YTD 2024 ((727.9)%)
EBITDA: $1,060 vs $2,432 in YTD 2024 ((56.4)%)
Adjusted EBITDA: $1,326 vs $2,699 in YTD 2024 ((50.9)%)

About Nortech Systems Incorporated:
Nortech Systems, based in Maple Grove, Minnesota, provides design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Serving medical imaging, medical device, aerospace & defense, and industrial markets. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS.

Forward-Looking Statements:
This press release contains forward-looking statements subject to risks and uncertainties detailed in the company’s filings with the Securities and Exchange Commission.

Reconciliation of GAAP Measures to Non-GAAP Financial Measures:
The press release includes EBITDA and Adjusted EBITDA, non-GAAP financial measures used by management to assess ongoing performance. Details of the reconciliation are in the financial tables provided.

Andrew D. C. LaFrence
Chief Financial Officer and Senior Vice President of Finance
alafrence@nortechsys.com
952-345-2243

Source: Nortech Systems Incorporated

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.